eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 19/04/2011
PIL Tarivid 200mg & 400mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/04/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 21/09/2010 and displayed until 19/04/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 08/06/2009 and displayed until 21/09/2010
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 30/07/2008 and displayed until 08/06/2009
Reasons for adding or updating:
  • Addition of joint PIL covering all presentations
  • Change due to user-testing of patient information
  • Removed by Datapharm
Updated on 29/04/2008 and displayed until 30/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 31/08/2005 and displayed until 29/04/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 19/04/2002 and displayed until 31/08/2005
Reasons for adding or updating:
  • Update to PIL

Active Ingredients/Generics

 
   ofloxacin